2023-510247-38-00招募中1 期
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF IA-14069 IN HEALTHY SUBJECTS, WITH AN EXTENSION TO EXPLORE ANY DRUG-DRUG INTERACTION POTENTIAL WITH METHOTREXATE (PART 1), AND IN PATIENTS WITH RHEUMATOID ARTHRITIS, WITH PRELIMINARY ASSESSMENT OF EFFICACY IN PATIENTS (PART 2)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 35
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Eun-Ju Jang
Scientific
Ilab Co. Ltd.
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder-F31F31PER-070-06OVARTIS BIOSCIENSES PERU S.A.,
未知
不适用
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE IIB DOSE FINDING STUDY OF GLPG0634 ADMINISTERED FOR 24 WEEKS IN COMBINATION WITH METHOTREXATE TO SUBJECTS WITHMODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAVE AN INADEQUATE RESPONSE TO METHOTREXATE ALONE-M06M06PER-057-13Galapagos N.V,
进行中（未招募）
1 期
Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients with mild Alzheimer's Disease (STEADFAST)EUCTR2016-002005-19-IEvTv THERAPEUTICS LLC800
进行中（未招募）
1 期
Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients with mild Alzheimer's Disease (STEADFAST)MILD ALZHEIMER'S DISEASE RECEIVING ACETYLCHOLINESTERASE INHIBITORS AND/OR MEMANTINEMedDRA version: 20.0Level: PTClassification code 10012271Term: Dementia Alzheimer's typeSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: HLTClassification code 10001897Term: Alzheimer's disease (incl subtypes)System Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: HLTClassification code 10012268Term: Dementia (excl Alzheimer's type)System Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10012296Term: Dementia of the Alzheimer's type, with depressed moodSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10012295Term: Dementia of the Alzheimer's type, with delusionsSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10012294Term: Dementia of the Alzheimer's type, with deliriumSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10012293Term: Dementia of the Alzheimer's type, uncomplicatedSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: LLTClassification code 10012292Term: Dementia of the Alzheimer's type NOSSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: LLTClassification code 10066571Term: Progression of Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2016-002005-19-GBvTv THERAPEUTICS LLC800
进行中（未招募）
不适用
RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTINATIONAL, MULTI-CENTRE, PHASE IIB/III STUDY OF THE EFFICACY AND SAFETY OF THREE DOSES OF SLIT ADMINISTERED AS TABLETS ONCE DAILY TO PATIENTS SUFFERING FROM GRASSES POLLEN RHINOCONJUNCTIVITISEUCTR2004-001910-15-ITSTALLERGENES